Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis

The Ki-1 antigen (CD30) is an established therapeutic target in patients with Hodgkin lymphoma and anaplastic large-cell lymphoma. We have recently shown that CD30 is expressed abundantly in the cytoplasm of neoplastic mast cells (MCs) in patients with advanced systemic mastocytosis (SM). In the cur...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Blood
Главные авторы: Blatt, Katharina, Cerny-Reiterer, Sabine, Schwaab, Juliana, Sotlar, Karl, Eisenwort, Gregor, Stefanzl, Gabriele, Hoermann, Gregor, Mayerhofer, Matthias, Schneeweiss, Mathias, Knapp, Sylvia, Rülicke, Thomas, Hadzijusufovic, Emir, Bauer, Karin, Smiljkovic, Dubravka, Willmann, Michael, Reiter, Andreas, Horny, Hans-Peter, Valent, Peter
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Hematology 2015
Предметы:
Myeloid Neoplasia
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4692143/
https://ncbi.nlm.nih.gov/pubmed/26486787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-03-637728
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы